NCT05852041View on ClinicalTrials.gov

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

June 7, 2027

Study Completion Date

June 7, 2035

Conditions
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8
Interventions
PROCEDURE

Biopsy of Prostate

Undergo MRI/PET prostate biopsy

GENETIC

Decipher Prostate Cancer Test

Undergo decipher

OTHER

Flotufolastat F-18 Gallium

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo PET-MRI

PROCEDURE

Multiparametric Magnetic Resonance Imaging

Undergo mpMRI

PROCEDURE

Positron Emission Tomography

Undergo PET-MRI

PROCEDURE

Radical Prostatectomy

Undergo radical prostatectomy

Trial Locations (1)

60611

RECRUITING

Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER